Restricted accessLetterFirst published online 2026-2
Comment on “Association Between Rocuronium Administration and Clinical Outcomes in Patients With Moderate-To-Severe Acute Respiratory Distress Syndrome: A Retrospective Cohort Study”
TonaiMSasabuchiYWatanabeHMatsuiHYasunagaH. Association between rocuronium administration and clinical outcomes in patients with moderate-to-severe acute respiratory distress syndrome: a retrospective cohort study [published online ahead of print March 28, 2025]. Ann Pharmacother. doi:10.1177/10600280251329195
2.
ParkSSchmidtM.Early neuromuscular blockade in moderate to severe acute respiratory distress syndrome: do not throw the baby out with the bathwater!J Thorac Dis. 2019;11(11):E231-E234. doi:10.21037/JTD.2019.10.25
3.
SpicerABCavalcantiABZampieriFG.Subgroup analyses and heterogeneity of treatment effects in randomized trials: a primer for the clinician. Curr Opin Crit Care. 2024;30(5):427-438. doi:10.1097/mcc.0000000000001186